Prediction of disease severity in neuromyelitis optica by the levels of interleukin (IL)-6 produced during remission phase.
Barros PO, Cassano T, Hygino J, Ferreira TB, Centurião N, Kasahara TM, Andrade RM, Linhares UC, Andrade AF, Vasconcelos CC, Alvarenga R, Marignier R, Bento CA.
Barros PO, et al. Among authors: alvarenga r.
Clin Exp Immunol. 2016 Mar;183(3):480-9. doi: 10.1111/cei.12733. Epub 2015 Dec 1.
Clin Exp Immunol. 2016.
PMID: 26472479
Free PMC article.